SEC Form 4 · accession 0001100682-26-000138
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Birgit Girshick
Officer — Chief Executive Officer · Director
Period of report
Aug 19, 2026
Accepted (ET)
Aug 20, 2026 · 4:37 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 19, 2026 | G | 528 | $0.00 | D | 35,485 | D | |
| Common Stock | holding | — | — | — | 43,803 | I | Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.